Illumina Sues Affymetrix Over Genetic Tech Patent
Genetic analysis company Illumina Inc. has sued Affymetrix Inc. for patent infringement, about 16 months after Illumina agreed to pay its rival $90 million to settle earlier patent litigation over DNA...To view the full article, register now.
Already a subscriber? Click here to view full article